Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSN-Methyldeoxynojirimycin is an inhibitor of α-glucosidases and glycoprotein processing.1 It inhibits the rabbit intestinal α-glucosidases sucrase and maltase (IC50s = 0.068 and 0.46 µg/ml, respectively) and R. niveus glucoamylase (IC50s = 1.6 and 4.7 µg/ml with starch or maltose as substrates, respectively).2 It is selective for these enzymes over β-glucosidase (IC50 = 363 µg/ml). N-Methyldeoxynojirimycin inhibits highly pathogenic avian influenza (HPAI) oligosaccharide processing in HPAI-infected chicken embryo cells.1 It reduces the cytopathic effect of HIV in infected Karpas-45 T cells.3 N-Methyldeoxynojirimycin also inhibits postprandial increases in blood glucose levels in sucrose-loaded rats (ED50 = 5.8 mg/kg).
WARNING This product is not for human or veterinary use.
1. N-
2. Inhibition of intestinal α-
3. Aminosugar derivatives as potential anti-